127 related articles for article (PubMed ID: 10831488)
1. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone.
Ngan ET; Yatham LN; Ruth TJ; Liddle PF
Am J Psychiatry; 2000 Jun; 157(6):1016-8. PubMed ID: 10831488
[TBL] [Abstract][Full Text] [Related]
2. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.
Rasmussen H; Erritzoe D; Andersen R; Ebdrup BH; Aggernaes B; Oranje B; Kalbitzer J; Madsen J; Pinborg LH; Baaré W; Svarer C; Lublin H; Knudsen GM; Glenthoj B
Arch Gen Psychiatry; 2010 Jan; 67(1):9-16. PubMed ID: 20048218
[TBL] [Abstract][Full Text] [Related]
3. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia.
Verhoeff NP; Meyer JH; Kecojevic A; Hussey D; Lewis R; Tauscher J; Zipursky RB; Kapur S
Psychiatry Res; 2000 Oct; 99(3):123-35. PubMed ID: 11068194
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.
Lewis R; Kapur S; Jones C; DaSilva J; Brown GM; Wilson AA; Houle S; Zipursky RB
Am J Psychiatry; 1999 Jan; 156(1):72-8. PubMed ID: 9892300
[TBL] [Abstract][Full Text] [Related]
5. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
Trichard C; Paillère-Martinot ML; Attar-Levy D; Recassens C; Monnet F; Martinot JL
Am J Psychiatry; 1998 Apr; 155(4):505-8. PubMed ID: 9545996
[TBL] [Abstract][Full Text] [Related]
6. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
[TBL] [Abstract][Full Text] [Related]
7. Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?
Rasmussen H; Frokjaer VG; Hilker RW; Madsen J; Anhøj S; Oranje B; Pinborg LH; Glenthøj B; Knudsen GM
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1248-50. PubMed ID: 27179966
[TBL] [Abstract][Full Text] [Related]
8. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
[TBL] [Abstract][Full Text] [Related]
9. Brain serotonin2 receptors in major depression: a positron emission tomography study.
Yatham LN; Liddle PF; Shiah IS; Scarrow G; Lam RW; Adam MJ; Zis AP; Ruth TJ
Arch Gen Psychiatry; 2000 Sep; 57(9):850-8. PubMed ID: 10986548
[TBL] [Abstract][Full Text] [Related]
10. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
Karlsson P; Farde L; Halldin C; Sedvall G
Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
[TBL] [Abstract][Full Text] [Related]
11. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.
Meyer JH; Kapur S; Eisfeld B; Brown GM; Houle S; DaSilva J; Wilson AA; Rafi-Tari S; Mayberg HS; Kennedy SH
Am J Psychiatry; 2001 Jan; 158(1):78-85. PubMed ID: 11136637
[TBL] [Abstract][Full Text] [Related]
12. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.
Yatham LN; Liddle PF; Dennie J; Shiah IS; Adam MJ; Lane CJ; Lam RW; Ruth TJ
Arch Gen Psychiatry; 1999 Aug; 56(8):705-11. PubMed ID: 10435604
[TBL] [Abstract][Full Text] [Related]
13. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S
Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
[TBL] [Abstract][Full Text] [Related]
14. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa.
Kaye WH; Frank GK; Meltzer CC; Price JC; McConaha CW; Crossan PJ; Klump KL; Rhodes L
Am J Psychiatry; 2001 Jul; 158(7):1152-5. PubMed ID: 11431241
[TBL] [Abstract][Full Text] [Related]
15. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors.
Massou JM; Trichard C; Attar-Levy D; Feline A; Corruble E; Beaufils B; Martinot JL
Psychopharmacology (Berl); 1997 Sep; 133(1):99-101. PubMed ID: 9335087
[TBL] [Abstract][Full Text] [Related]
16. No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.
Trichard C; Paillère-Martinot ML; Attar-Levy D; Blin J; Feline A; Martinot JL
Schizophr Res; 1998 May; 31(1):13-7. PubMed ID: 9633832
[TBL] [Abstract][Full Text] [Related]
17. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
[TBL] [Abstract][Full Text] [Related]
18. Greater loss of 5-HT(2A) receptors in midlife than in late life.
Sheline YI; Mintun MA; Moerlein SM; Snyder AZ
Am J Psychiatry; 2002 Mar; 159(3):430-5. PubMed ID: 11870007
[TBL] [Abstract][Full Text] [Related]
19. In vivo 5-HT
Radhakrishnan R; Matuskey D; Nabulsi N; Gaiser E; Gallezot JD; Henry S; Planeta B; Lin SF; Ropchan J; Huang Y; Carson RE; D'Souza DC
Psychiatry Res Neuroimaging; 2020 Jan; 295():111007. PubMed ID: 31760336
[TBL] [Abstract][Full Text] [Related]
20. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
